Data from FDA - Curated by EPG Health - Last updated 27 July 2017

Indication(s)

INDICATIONS & USAGE SECTION Catatacts Formulated for symptoms associated with cataracts such as blurred vision, photophobia, diplopia and opacities.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Anti-integrins in IBD

Anti-integrins in IBD

See presentations from a satellite symposium presented at UEG Week 2018, with a particular focus on rapid and sustained efficacy in IBD through biologics along with a need to utilise patient-empowered treatment models.

Load more

Related Content

Usage information

Dosing and administration
DOSAGE & ADMINISTRATION SECTION Directions: Ages 12 and up, take 6 pellets orally one to four times daily or as directed by a healthcare professional.

More information

Category Value
Agency product number 877L01IZ0P
Orphan designation No
Product NDC 55714-4589
Date Last Revised 01-06-2011
Type HUMAN PRESCRIPTION DRUG
List of excipients INACTIVE INGREDIENT SECTION Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
Marketing authorisation holder Newton Laboratories, Inc.